Document

CVM Guidance for Industry #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated

ICR 202512-0910-001 · OMB 0910-0032 · Object 164466800.

Document Viewer [pdf]

Status: No verified local artifact is currently available. The document remains flagged for repair and upstream re-check.

Queue: Repair is queued and waiting for the next worker pass. (priority 140 · attempts 10 · next 2026-08-06 11:49:40)

Missing: pdf

No local or Spaces-backed artifact is available yet for this document.

Primary: pdfSource: application/octet-stream
Loading document viewer…

Document Metadata

Record metadata
application/octet-stream
CVM Guidance for Industry #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated
Bioequivelance, Soluble, 171, Center for Veterinary Medicine, CVM, guidance, GFI, Aqueous, Type A Medicated Articles
FDA CVM
2025-12-01
2023-06-08
failed_conversion